Postvaccine Anti-SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients
Kidney Int Rep
.
2021 Jun;6(6):1699-1700.
doi: 10.1016/j.ekir.2021.04.017.
Epub 2021 Apr 23.
Authors
Syed Ali Husain
1
,
Demetra Tsapepas
2
,
Kathryn F Paget
1
,
Jae-Hyung Chang
1
,
R John Crew
1
,
Geoffrey K Dube
1
,
Hilda E Fernandez
1
,
Heather K Morris
1
,
Sumit Mohan
1
3
,
David J Cohen
1
Affiliations
1
Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
2
New York- Presbyterian Hospital, New York, New York, USA.
3
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
PMID:
33907723
PMCID:
PMC8062410
DOI:
10.1016/j.ekir.2021.04.017
No abstract available
Grants and funding
KL2 TR001874/TR/NCATS NIH HHS/United States